Ginkgo Bioworks Holdings (DNA) FCF Margin (QoQ) (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,517.00 |
| Dec 31, 2025 | -4,200.00 |
| Sep 30, 2025 | -1,706.00 |
| Jun 30, 2025 | 4,804.00 |
| Mar 31, 2025 | 10,721.00 |
| Dec 31, 2024 | -12,345.00 |
| Sep 30, 2024 | 2,417.00 |
| Jun 30, 2024 | 11,323.00 |
| Mar 31, 2024 | -21,347.00 |
| Dec 31, 2023 | 3,868.00 |
| Sep 30, 2023 | 2,993.00 |
| Jun 30, 2023 | 2,827.00 |
| Mar 31, 2023 | 1,303.00 |
| Dec 31, 2022 | -9,222.00 |
| Sep 30, 2022 | 1,341.00 |
| Jun 30, 2022 | -6,006.00 |
| Mar 31, 2022 | 6,672.00 |
| Dec 31, 2021 | -6,347.00 |
| Sep 30, 2021 | 12,133.00 |
| Jun 30, 2021 | 2,381.00 |